Answers from the Lab

Ruifeng (Ray) Guo, M.D., Ph.D., explains how Mayo Clinic Laboratories' expanded melanoma panel can enhance patient care. The updated assay provides more comprehensive genomic coverage to better classify melanoma tumors and guide treatment decisions.

Show Notes

(00:32)
 Could you provide a little bit of background about yourself?

(01:43)
 Could you give a brief overview of the new melanoma assay?

(04:53)
 Is the assay able to provide diagnostic, prognostic and classification information, and potential therapeutic implications?

(05:12)
 Could you talk a little more about the MSI assessment in this panel? 

(05:59)
 Which patients should have this testing?

(07:01)
 How are these results used in patient care?

(08:39)
 Is there anything else you'd like to add?

What is Answers from the Lab?

A Mayo Clinic curated podcast sharing Mayo Clinic knowledge and advancements on the state of testing, science, and people who are making it happen behind the scenes.